Table 1 Surface markers expressed by MSCs from different sources
Sources | Surface markers | Application prospect |
|---|---|---|
Adipose | CD13, CD90, CD105, STRO-1 [5] | Osteoarthritis, Multiple Sclerosis[6] |
Bone marrow | CD90, CD105, CD146, CD271[7] | Stroke, Parkinson’s disease, Alzheimer’s disease[8] |
Synovial membrane | CD44, CD73, CD90, CD105[9] | Rheumatoid arthritis, cartilage repair[10] |
Perivascular | CD90, CD105, CD248, CD271[11] | |
Umbilical cord blood | CD44, CD73, CD90, CD105[13] | Ameliorating psoriasis-like skin lesion[14] |
Umbilical cord tissue | CD44, CD73, CD90, CD105[15] | Corneal epithelial repair[15] |
Placenta | CD29, CD73, CD90, CD105[16] | Attenuating spinal cord injury in mice [16] |
Menstrual blood | CD29, CD73, CD90, CD105[17] | Treating critically ill COVID-19 patients [17] |
Dental pulp | CD73, CD90, CD105[18] | Autism spectrum disorder,metatropic dysplasia [19] |